Literature DB >> 426398

Nerve conduction abnormalities in untreated maturity-onset diabetes: relation to levels of fasting plasma glucose and glycosylated hemoglobin.

R J Graf, J B Halter, E Halar, D Porte.   

Abstract

The role of metabolic abnormalities in the development of diabetic neuropathy is controversial. To investigate the influence of hyperglycemia on nerve conduction, we studied 20 untreated maturity-onset diabetic patients and 23 normal control subjects of similar age. Nerve conduction velocity of motor (median, peroneal, and tibial) and sensory (median and sural) nerves in diabetic patients was significantly slowed and H-reflex latency time prolonged. Levels of fasting plasma glucose in diabetic subjects were correlated with slowed motor conduction velocity of the median, peroneal, and tibial nerves but not with sensory nerve conduction velocities. Levels of glycosylated hemoglobin, an index of long-term glycemia, were correlated with slowing of peroneal motor conduction velocity in diabetic patients. These associations could not be explained by patient age or duration of diabetes. These findings suggest that the degree of hyperglycemia of untreated maturity-onset diabetes contributes to the motor nerve conduction abnormalities in this disease.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 426398     DOI: 10.7326/0003-4819-90-3-298

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  16 in total

1.  Hyperalgesia in spontaneous and experimental animal models of diabetic neuropathy.

Authors:  L Wuarin-Bierman; G R Zahnd; F Kaufmann; L Burcklen; J Adler
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

2.  Effects of one year of near-normoglycemia on peripheral nerve function in type 1 (insulin-dependent) diabetic patients.

Authors:  D Ziegler; K Wiefels; K Dannehl; F A Gries
Journal:  Klin Wochenschr       Date:  1988-05-02

3.  Effect of plasma glucose control by continuous subcutaneous insulin infusion on nerve conduction.

Authors:  P M Bell; B Sawhney; J R Hayes; D R Hadden
Journal:  Ir J Med Sci       Date:  1985-10       Impact factor: 1.568

Review 4.  Sorbitol, myo-inositol and sodium-potassium ATPase in diabetic peripheral nerve.

Authors:  D A Greene
Journal:  Drugs       Date:  1986       Impact factor: 9.546

5.  Treatment of peripheral neuropathies.

Authors:  M Hallett; D Tandon; A Berardelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

6.  Structural and functional consequences of increased tubulin glycosylation in diabetes mellitus.

Authors:  S K Williams; N L Howarth; J J Devenny; M W Bitensky
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

7.  Peripheral nerve function in relation to quality of metabolic control in diabetes.

Authors:  F W Bertelsmann; J J Heimans; J C van Rooy; C Popp-Snijders; E A van der Veen
Journal:  J Neurol       Date:  1987-06       Impact factor: 4.849

8.  Clinical and neurophysiological studies with the aldose reductase inhibitor, sorbinil, in symptomatic diabetic neuropathy.

Authors:  I G Lewin; I A O'Brien; M H Morgan; R J Corrall
Journal:  Diabetologia       Date:  1984-06       Impact factor: 10.122

9.  Nerve function and its determinants in patients with newly-diagnosed type 2 (non-insulin-dependent) diabetes mellitus and in control subjects--a 5-year follow-up.

Authors:  J M Lehtinen; L Niskanen; K Hyvönen; O Siitonen; M Uusitupa
Journal:  Diabetologia       Date:  1993-01       Impact factor: 10.122

10.  Sodium- and energy-dependent uptake of myo-inositol by rabbit peripheral nerve. Competitive inhibition by glucose and lack of an insulin effect.

Authors:  D A Greene; S A Lattimer
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.